Free Trial

Portage Biotech (PRTG) SEC Filings & 10K Form

Portage Biotech logo
$8.03 -1.08 (-11.86%)
Closing price 03:59 PM Eastern
Extended Trading
$8.07 +0.04 (+0.56%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Portage Biotech SEC Filings

DateFilerForm TypeView
08/01/2025
4:24 PM
Portage Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/28/2025
8:00 AM
Portage Biotech (Filer)
Form 424B3
07/25/2025
3:20 PM
Portage Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/25/2025
3:25 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2025
3:31 PM
Portage Biotech (Filer)
Form 424B3
06/27/2025
3:25 PM
Portage Biotech (Filer)
Form 424B3
06/25/2025
6:26 AM
Portage Biotech (Filer)
Form 424B3
06/25/2025
6:15 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2025
6:00 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2025
6:14 AM
Portage Biotech (Filer)
Form 424B3
05/29/2025
3:30 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2025
11:15 PM
Portage Biotech (Filer)
Form EFFECT
04/28/2025
5:20 AM
Portage Biotech (Filer)
Form 424B3
04/28/2025
5:10 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
3:37 PM
Portage Biotech (Filer)
Form 424B3
03/13/2025
3:34 PM
Portage Biotech (Filer)
Form 424B3
03/12/2025
7:20 AM
Portage Biotech (Filer)
Form 424B3
03/12/2025
7:10 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2025
3:25 PM
Portage Biotech (Filer)
Form 424B3
02/12/2025
3:20 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/06/2025
5:00 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/06/2025
5:12 AM
Portage Biotech (Filer)
Form 424B3
12/19/2024
3:43 PM
Mellon James (Filed by)
Portage Biotech (Subject)
Form SCHEDULE 13D/A
12/17/2024
6:05 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
6:11 AM
Portage Biotech (Filer)
Form 424B3
12/13/2024
3:35 PM
Portage Biotech (Filer)
Form 424B3
12/13/2024
3:15 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
4:01 PM
Portage Biotech (Filer)
Form 424B3
12/12/2024
3:30 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2024
3:35 PM
Portage Biotech (Filer)
Form 424B3
12/05/2024
3:28 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
3:47 PM
Portage Biotech (Filer)
Form 424B3
11/26/2024
3:25 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
3:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Portage Biotech (Subject)
Form SC 13G/A
10/04/2024
3:30 PM
Portage Biotech (Filer)
Form 424B3
10/04/2024
3:15 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2024
8:18 PM
Portage Biotech (Subject)
Shaw Allan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
3:28 PM
Portage Biotech (Subject)
Shaw Allan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
8:41 AM
MINTZ STEVEN (Reporting)
Portage Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
10:25 AM
Bailey Gregory (Reporting)
Portage Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
11:15 PM
Portage Biotech (Filer)
Form EFFECT
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).tc pixel

Click here for the names of our three top stocks to own this year (no purchase necessary).
08/27/2024
7:30 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
5:05 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
5:11 AM
Portage Biotech (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PRTG) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners